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Abstract
Background: Self-sampling for HPV testing may be a method to increase overall cervical cancer screening rates
among Black women, who are underscreened for cervical cancer in parts of the US. The purpose of this study was
to assess preferred characteristics for delivery of HPV self-sampling kits, return of HPV self-sampling kits, and
communication of HPV test results and explore sociodemographic factors (income, education, and marital status)
associated with acceptability of self-sampling for HPV testing.
Methods: Survey data were gathered at an Indiana minority health fair. Participants evaluated 9 scenarios that
varied along 3 dimensions: HPV self-sampling kit delivery (mail, pharmacy pick-up, or clinic pick-up), HPV self-
sampling kit return (mail, pharmacy drop-off, or clinic drop-off), and HPV test results (mail, phone call, or text
message). The 9 scenarios were produced from a fractional factorial design and rated on a 0 to 100 scale. Ratings-
based conjoint analysis (RBCA) determined how each dimension influenced ratings. A measure for acceptability of
self-sampling was obtained from the ratings of all 9 scenarios. The acceptability measure was regressed on
sociodemographics.
Results: The 98 participants ranged in age from 21 to 65 (M = 45). Across the 9 scenarios, overall acceptability to
self-sample had a mean of 60.9 (SD = 31.3). RBCA indicated that HPV self-sampling kit return had the most influence
on ratings, followed by HPV self-sampling kit delivery, and finally, HPV test result communication. Thirty-six percent
of participants rated all self-sampling scenarios the same. Sociodemographic characteristics were not associated
with acceptability of self-sampling.
Conclusions: Self-sampling for HPV testing was found to be generally acceptable to Black women in this pilot
survey study. This information could be used by researchers developing self-sampling interventions and the
implementation of self-sampling among providers.
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Background
Black women in the United States (US) continue to bear
an unequal burden of cervical cancer, which is a salient
problem in Indiana where Black women have a 23%
higher cervical cancer incidence [1] and 25% higher
mortality [2] rate compared to White women. Addition-
ally, Black women in Indiana have one of the lowest cer-
vical cancer screening rates in the nation with over 25%
of Black women outside of screening guidelines [3].
Currently, the United States Preventive Services Task
Force (USPSTF) guidelines for cervical cancer screening
include: clinic-based screening options with 1.) cytology
alone every 3 years (age 21–65), 2) co-testing of cytology
and human papillomavirus (HPV) every 5 years (age 30–
65), or 3) an HPV test alone every 5 years (age 30–65)
[4]. Self-sampling for human papillomavirus (HPV) test-
ing, a method for women to collect their own cervicova-
ginal sample, is one technology that has been explored
in the US and internationally as an alternative to clinic-
based cervical cancer screening. Self-sampling for HPV
testing is well documented as having comparable sensi-
tivity to clinician-collected HPV samples [5, 6]. Self-
sampling for HPV testing may be a method to over-
come the many structural and personal barriers among
Black women related to clinic-based testing including
transportation [7, 8], childcare [7, 8], embarrassment
[9], pain [10], and fear [8, 10]. Self-sampling for HPV
testing could increase cervical cancer screening rates
and decrease morbidity and mortality from cervical
cancer.
Self-sampling for HPV testing has been integrated into
screening programs in other countries (the Netherlands
[11] and Australia [12]) and is a potential screening
strategy of interest in the US. Several studies in the US
have examined acceptability of self-sampling for HPV
testing and found it acceptable [13–16]. One study
among Kentucky Appalachian women found a 100% ac-
ceptance rate for clinic-based delivery and return of self-
sampling for HPV testing [17]. Another study examined
the feasibility and acceptability of a mail-based delivery
and return of HPV self-sample kits among low-income
women and found a high acceptability rate of 82% for
mail-based delivery and return [13]. Few studies, how-
ever, have examined women’s preferences for self-
sampling for HPV testing considering delivery and re-
turn of HPV self-sampling kits and delivery of results.
One study found that most women reported to prefer
receiving the HPV self-sample kit in the mail (compared
to receiving it in the pharmacy or clinic) [13]. This
study, however, did not examine possible ways women
would prefer to return an HPV self-sample kit (mail,
pharmacy drop-off, or clinic drop-off) or how they
would prefer to receive HPV test results (mail, phone
call, or text message).
The purpose of the current pilot survey study was to
assess the relative importance of HPV self-sampling
characteristics and willingness to use HPV self-sampling
in a specific, but relevant demographic group, Black
women from the state of Indiana, U.S.A. The testing
characteristics or dimensions included delivery of an
HPV self-sampling kit (mail, pharmacy pick-up, clinic
pick-up), return of the HPV self-sampling kit (mail,
pharmacy drop-off, clinic drop-off), and how women
would like the results delivered (mail, phone call, or text
message). Ratings-based conjoint analysis (RBCA), a
methodological and analytic technique, is uniquely
suited to this research focus, as it evaluates how a prod-
uct’s characteristics (in this case, HPV self-testing) influ-
ence product preferences. A secondary aim was to
explore sociodemographic characteristics that could be
related to self-sampling for HPV testing acceptability.
Although studies have begun to examine acceptability
related to self-sampling for HPV testing in the US, it is
important to understand these preferences along
multiple dimensions (delivery and return of HPV self-
sampling kits and HPV results delivery) especially
among Black women who have higher incidence and
mortality from cervical cancer. Results of this pilot
survey study could inform future interventions or imple-
mentation of self-sampling for HPV testing by determin-
ing which factors are most important to women’s
willingness to use this technology.
Methods
Sample and study design
This study was submitted to and approved as exempt re-
search by the Indiana University IRB. Participants gave
verbal consent as signed consent is not required for ex-
empt research according to Indiana University IRB. The
participants were provided a verbal and written descrip-
tion of the study. The written description included the
following information: that subjects were being asked to
participate in research; a description of the study proce-
dures; a statement regarding any potential risks or bene-
fits of participation; a statement that participation is
voluntary; and the name, affiliation, and contact infor-
mation of the researchers.
The data were collected from women who attended
the health fair portion of the Annual Indiana Black
Expo, a large cultural event that draws an estimated
40,000 attendees. Eligibility inclusion criteria included
women who were 1.) Black, 2.) between the ages of
21–65 (age range for cervical cancer screening ac-
cording to USPSTF guidelines), and 3.) could read
and write English. Exclusion criteria included women
with a hysterectomy. A sample of 98 women were in-
cluded in analysis. The sample size was limited by the in-
clusion criteria, the availability of research personnel, and
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the many health vendors with displays at the health fair
(i.e., many potential participants may have not wanted to
take the extra time required to complete the survey). Par-
ticipants were given the choice between a computer sur-
vey administered on REDCap (n = 58) or paper surveys
(n = 40) after determining eligibility and explanation of the
study. Participants were compensated with a $20 gift card
after completing the survey.
Measures
Basic sociodemographic characteristics were assessed by
self-report, including income (divided at the $30,000
point, which represents approximately 200% of the pov-
erty level for a 2-person household), education, and
marital status of participants. Then, participants were
given a description of self-sampling for HPV testing and
asked to evaluate hypothetical self-sampling scenarios
that varied along 3 dimensions: delivery of an HPV self-
sampling kit (mail, pharmacy pick-up, clinic pick-up),
return of the HPV self-sampling kit (mail, pharmacy
drop-off, clinic drop-off), and HPV result delivery (mail,
phone call, or text message). A full factorial design
would have required women to rate 27 scenarios, which
would have imposed undue burden on the respondents.
Therefore, we generated a fractional factorial design
using the conjoint analysis procedure available in SPSS
version 24 (IBM Corp., Armonk, NY) to create nine rep-
resentative, independent scenarios that allowed us to
evaluate the main effects of the dimensions. An example
of a scenario presented to participants was “An HPV
self-sampling kit delivered by mail that could be
returned by mail with results delivered by text message.
If self-sampling were available today, and you had time,
how likely would you be to complete self-sampling in
the given scenario?”. Participants rated the scenarios on
an 11-point scale in intervals of 10 points (1–100) where
0 represented that they would never complete self-
sampling for HPV testing and 100 meant that they
would definitely complete self-sampling for HPV testing.
Acceptability for HPV self-sampling in general was eval-
uated by creating a scale score based on the mean value
across the 9 items illustrating hypothetical self-sampling
scenarios (Cronbach’s alpha = .94).
Analysis
We used SPSS 24 to describe sociodemographic charac-
teristics for all 98 participants and the 63 participants
who did not assign the same ratings to all scenarios.
Then, RBCA was used to examine how HPV self-sample
kit characteristics influenced ratings for participants
(n = 63) who did not assign the same ratings to all sce-
narios. Participants who assigned the same ratings to all
scenarios were not included in analyses. Nine hypothet-
ical self-sampling scenarios were each defined along 3
dimensions: delivery of HPV self-sampling kit (mail,
pharmacy pick-up, or clinic pick-up), return of HPV
self-sampling kit (mail, pharmacy drop-off, or clinic
drop-off), and delivery of HPV results (mail, phone call,
text message). Income, education, and marital status
were regressed on the HPV testing acceptability measure
(created from the 9 items illustrating different hypothet-
ical self-sampling for HPV testing scenarios among all
98 women) in a linear regression model.
RBCA is a regression-based technique used to under-
stand how product preferences are influenced by prod-
uct attributes and has been validated for use in previous
health-related research [18–20]. RBCA allows respon-
dents to consider attributes simultaneously so that re-
spondents can make trade-offs. Conjoint analysis of the
9 scenarios revealed the relative preferences, named
part-worth utilities in conjoint analysis, participants
placed on each dimension. For example, in the dimen-
sion of HPV self-sampling kit return, the preference
placed on the attribute of mailed delivery of HPV self-
sampling kit is reflected in a higher part-worth utility
score compared to the part-worth utility scores of clinic
or pharmacy pick-up. A negative part-worth utility score
indicates a relative dislike for an attribute (such as clinic
pick-up of HPV self-sampling kit) and a positive part-
worth utility score shows a relative preference for an at-
tribute. A wider range of part-worth utility attribute
scores across a given dimension has a greater influence
on importance scores than a dimension with a smaller
range in values. The sum of the part-worth utilities
needs to equal zero in each of the 3 dimensions. Import-
ance scores were calculated by the relative ranges of
part-worth utilities across the 3 dimensions, and in this
approach, the sum of importance scores across dimen-
sions must equal 100. The higher the importance score
for a given dimension (such as HPV self-sampling kit re-
turn), the greater the influence on acceptability of a
given scenario.
Results
Sample
Sociodemographics (income, education, marital status)
of the women who rated the scenarios differently (n =
63) and were therefore included in the conjoint analysis
and the total sample (n = 98) were examined (Table 1).
Of the 98 participants, 36% (n = 35) rated all the scenar-
ios the same. Sixty percent (n = 21) of the sample who
rated the scenarios the same held strongly positive views
of self-sampling (Table 2) while 23% (n = 8) had strongly
negative views. Seventeen percent (n = 6) held midpoint
views. The 35 participants who demonstrated no vari-
ability across the vaccine scenarios were necessarily
eliminated from the conjoint analysis. The overall con-
joint analysis was based on the 63 participants who did
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not rate all the vaccine scenarios the same and provided
responses for all nine scenarios.
Self-sampling for HPV testing acceptability
Across the 9 scenarios, overall willingness to self-sample
ranged from 0 to 100 with a mean of 60.9 (SD = 31.3).
The least acceptable self-sample scenario, “An HPV self-
sampling kit picked up at the clinic that could be
returned by mail with results delivered by mail”, received
a mean score of 60.4 (SD = 36.5). The most acceptable
self-sample scenario was “An HPV self-sampling kit
picked up at the clinic, returned to the pharmacy, and
results delivered by phone” (mean 64.7, SD = 35). Table 3
lists the mean scores and standard deviations of each
scenario. A linear regression analysis of income, education,
and marital status on the HPV testing acceptability measure
(among all 98 women) was not associated with self-
sampling acceptability. The overall regression (F = .443, df =
3, p = .723) found an R2 of .014.
For the 63 participants in the conjoint analysis, the part-
worth utilities in Fig. 1 illustrate that the most important
decisional factor (importance score = 40.6 (Fig. 2)) was HPV
self-sampling kit return with a preference for returning the
HPV self-sampling kit to the pharmacy rather than to the
clinic or mailing the HPV self-sampling kit. The next most
important decisional factor (importance score =
31.9 (Fig. 2)) was HPV self-sampling kit delivery, and
participants preferred mailed delivery of the HPV self-
sampling kit over pharmacy or clinic pick-up as illus-
trated by the part-worth utilities in Fig. 1. The least
important decisional factor was the HPV test results
delivery (importance score = 27.4 (Fig. 2)) with partici-
pants preferring a phone call over a text message or
mailed delivery of HPV results (Fig. 1). The conjoint
procedure examines correlative fit between the derived
fit and data. The overall conjoint analysis model dem-
onstrated a fit with the data with a Pearson R of .98.
Discussion
Self-sampling for HPV testing acceptability
The current study evaluated factors related to the
willingness of participants to engage in HPV testing
for self-sampling. Previous studies that have examined
HPV self-sampling acceptability have not used RBCA
to allow examination of multiple dimensions of HPV
self-sampling that could be important in implementa-
tion of the technology. The factors measured in the
current study included: delivery of an HPV self-
sampling kit (mail, pharmacy pick-up, clinic pick-up),
return of the HPV self-sampling kit (mail, pharmacy
drop-off, clinic drop-off), and how women would like
the results delivered (mail, a phone call, or a text
message). Overall acceptability appeared to be mostly
positive with a mean score of 60.9 and the lowest
mean score 60.4. A previous study using clinic-based de-
livery and return of self-sampling found an acceptability
rate of 100% [17], however, the authors measured
acceptability by participation in the study rather than an
acceptability scale or conjoint analysis. Another study
found an acceptability rate of 82% with a mail-based deliv-
ery and return of HPV self-sampling kits using acceptabil-
ity measures [13]. Our lower overall acceptability rate may
reflect that a different methodology, conjoint analysis, was
used to examine acceptability. Additionally, the women in
the current study had not actually used the HPV self-
sample kit, and women may become more comfortable
with self-sampling after using an HPV self-sampling kit.
Self-sampling for HPV testing characteristics
The current study found that most participants (n = 63)
did discriminate between the different self-sampling for
HPV testing scenarios. The most important self-
sampling for HPV testing characteristic was kit return
with a preference for return to a pharmacy. Although
some aspects of HPV self-sampling kit return have been
measured before, studies have not examined if other
methods of return (pharmacy or clinic) would be pre-
ferred to mailed return. A previous study found that a
majority of participants (82%) reported being comfort-
able sending the kit through the mail [13], but most
Table 1 Sociodemographics of those who were included in the
conjoint analysis (n = 63) and the total sample (n = 98)
Variable Participants included in
conjoint analysis (n = 63)
Total participants
(n = 98)
Income, n (%)
≥ $30,000 17 (27) 34 (35)
< $30,000 45 (73) 63 (65)
Education, n (%)
< 4-year degree 33 (52) 55 (56)
≥ 4-year degree 30 (48) 43 (44)
Marital Status, n (%)
Married or partner 24 (38) 34 (35)
Divorced, widowed
separated, or single
39 (62) 64 (65)
Table 2 Ratings and number of participants who rated all self-
sampling for HPV testing scenarios with the same rating (n = 35)
Rating Number of participants
100 21
50 5
25 1
5 1
1 3
0 4
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participants who responded to the survey had returned
the HPV self-sampling kit through the mail so were
most likely comfortable with mailed return. Little is
known about the women who did not return the HPV
self-sample kit through the mail, and those women may
have more problems with mail-based return of HPV
self-sampling kits, due to the reduction of neighborhood
mail boxes and the difficulty of traveling to a post office
[21] . Further research is needed to determine structural
barriers related to mailed return of HPV self-sampling
kits such as availability of a mailbox, proximity of a mail-
box to home, or other access factors. Not surprisingly,
clinic-based return of HPV self-sampling kits was least
favorable likely because of structural barriers such as
transportation and clinic hours. A pharmacy may be
open 24 h and have many locations whereas a clinic is
usually only open during business hours during the day
and may not be as close to home or work as a
pharmacy.
The next most important characteristic related to self-
sampling for HPV testing was HPV self-sample kit deliv-
ery. In line with a previous study that found 99% of
women preferred receiving the HPV self-sampling kit in
the mail, women in this study preferred to receive an
HPV self-sampling kit in the mail as opposed to the
clinic or pharmacy [13]. Mail-based delivery overcomes
structural barriers related to the least favorable option,
the clinic, and is more convenient than the pharmacy.
The least important characteristic related to self-
sampling for HPV testing was the HPV test result deliv-
ery. Participants preferred receiving a phone call about
HPV results, and a previous study found that 97% of
women were comfortable with receiving their HPV re-
sults over the phone [13]. This may reflect that women
Table 3 Self-sampling for HPV testing scenarios presented to participants
HPV self-sampling kit delivery HPV self-sampling kit return HPV test result delivery method Mean Score Standard Deviation
Mail Mail Text Message 63.48 36.82
Mail Pharmacy Mail 63.31 36
Mail Clinic Phone Call 63.24 35.38
Pharmacy Clinic Text Message 62.63 35.13
Pharmacy Mail Mail 63.24 35.69
Pharmacy Pharmacy Phone Call 63.44 34.61
Clinic Pharmacy Phone Call 64.73 34.98
Clinic Clinic Text Message 60.51 36.09
Clinic Mail Mail 60.35 36.45
Fig. 1 Conjoint analysis of the relative preferences (part-worth utilities) for different self-sampling for HPV testing scenarios
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want to ask questions or receive more information about
their diagnosis than a mailed letter or text message would
provide. Prior literature has shown that women often do
not understand the implications of a positive HPV test or
what a positive HPV diagnosis means [22, 23]. An HPV
diagnosis is often associated with stigma, anxiety, and dis-
tress [22, 24, 25]. An interaction with a healthcare pro-
vider may alleviate these negative feelings more so than an
impersonal contact method such as a mailed letter or text
message. One study found that women preferred to re-
ceive HPV information from a healthcare provider rather
than printed information [26]. Women may also be wor-
ried about loss of confidentiality of their diagnosis in a
mailed letter or text message. Further research is needed
to determine the best methods for delivering HPV results
to patients and the HPV information that patients would
like to know.
This study has several limitations. First, the participants
were all from a minority health fair and Black, which may
limit generalizability. Other populations may find self-
sampling for HPV testing more or less acceptable and/or
have different preferences than this specific subgroup. For
example, a study of British women found that HPV testing
was more acceptable among White women [27]. The
higher educational levels of this sample may not be repre-
sentative of all Black populations. Second, the sample size
of women who did not answer all the scenarios the same
was small (n = 63). Further research with a larger, more
representative population is necessary to more fully
understand characteristics related to acceptability of self-
sampling for HPV testing and potential sociodemographic,
health belief, and knowledge predictors of acceptability.
Third, other self-sampling characteristics not measured,
such as device type or invitation method, could be more
important than those measured in the current study. For
example, a recent study found that most participants
responded to an invitation to opt into a self-sampling for
HPV testing study by mail (61%) or online (37%) rather
than by phone (1%) or email (< 1%) [28]. Due to the re-
petitive nature of the scenarios, participants may have felt
response burden to the questions and were more likely to
leave a question blank, answer the scenarios with the same
score, or did not make trade-offs when considering self-
sampling characteristics. Fourth, although a description of
self-sampling for HPV testing was provided, participants
may have had difficulty imagining the kit and scenarios.
This could be potentially overcome by showing partici-
pants a kit and instructions for self-sampling prior to ad-
ministration of a survey.
Conclusions
In summary, self-sampling was found to be generally ac-
ceptable to Black women in this pilot survey study. The
most important characteristic among the women related
to self-sampling was the return of the HPV self-
sampling kit, second, delivery of the kit, and finally the
HPV results delivery method. Sociodemographic charac-
teristics including income, education, and marital status
were not related to self-sampling for HPV testing ac-
ceptability. If these findings can be replicated among the
general population or underscreeners, the information
could be used by researchers developing interventions
related to self-sampling for HPV testing and the imple-
mentation of self-sampling among providers.
Fig. 2 Contribution of each self-sampling for HPV testing characteristic to overall self-sampling importance scores
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